DOI:
10.1055/s-00034923
Adipositas - Ursachen, Folgeerkrankungen, Therapie
LinksClose Window
References
Artaç M, Korkmaz L, Coşkun H. et al.
Bevacuzimab may be less effective in obese metastatic colorectal cancer patients.
J Gastrointest Cancer 2019;
50: 214-220
DOI: 10.1007/s12029-017-0047-2.
We do not assume any responsibility for the contents of the web pages of other providers.